mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.03 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.04 |